amoxicillin non prescription
Feature Screens

5 Undervalued Companies for the Defensive Investor Near 52 Week Lows – August 2018

There are a number of great companies in the market today. By using the┬áModernGraham Valuation Model, I’ve selected the five undervalued companies reviewed by ModernGraham trading closest to their 52 week low. Each of these companies has been determined to be suitable for the Defensive Investor according to the┬áModernGraham approach.

Read More
Feature Value Investing Weekly

47 Companies in the Spotlight This Week – 5/16/15

We evaluated 47 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

Read More
Pharmaceuticals Stocks

McKesson Corp (MCK) Annual Valuation – 2014

McKesson Corp is not suitable for either the Defensive Investor or the Enterprising Investor. The Defensive Investor has concerns with the low current ratio, lack of earnings stability over the last ten years, and the high PEmg and PB ratios, while the Enterprising Investor is concerned with the high level of debt relative to the current assets.

Read More
Back To Top